Scholars Central

Conference abstractPublished 3 Jan 2018

Chemotherapy-induced adverse effects in the gastrointestinal tract and role of cannabinoids

Authors: Raquel Abalo

Universidad Rey Juan Carlos, Spain

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Chemotherapy, intended to kill cancerous cells, is also toxic to healthy cells. In the gastrointestinal tract, three main types of adverse effects may be induced: nausea/emesis; diarrhea; constipation. Each kind of antineoplastic drug may induce one or more of these effects. For example, cisplatin is considered highly emetogenic and induces both acute and delayed nausea and vomit, associated to alter gastric emptying and gastric distension. 5-fluorouracil induces diarrhea, potentially fatal due to dehydration. Finally, constipation is typically induced by drugs like vincristine, with the development of paralytic ileus. The three drugs alter the gut wall architecture, with the development of mucositis of different degrees and evolution after treatment finalization. Several lines of evidence, mainly in experimental animals, have shown that manipulating the endocannabinoid system may be beneficial to prevent/treat the effects on gastrointestinal motility. Thus, although their effects are not that clear in rodents, which do not vomit, cannabinoid agonists have been shown to reduce signs of nausea/emesis in animals capable of vomiting and they are actually used in the clinic as antiemetic adjuvants. Cannabinoid agonists may be useful, even at low, non-psychoactive doses, to reduce chemotherapy-induced diarrhea. Finally, cannabinoid antagonists were shown to reduce paralytic ileus induced by vincristine in a rat model, suggesting that endo-cannabinoid activity is increased by this antineoplastic drug. Thus, cannabinoid-based drugs could be used to relieve and prevent chemotherapy-induced adverse effects in the gastrointestinal tract and could then contribute to better preserve quality of life of cancerous patients during treatment.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Gastrointestinal & Digestive System.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Gastrointestinal & Digestive System
  • SubjectGastroenterology & Hepatology
  • BylineArticles whose byline prints “Raquel Abalo”